Biodegradable poly(DL-lactic-co-glycolic acid) microspheres containing tetracaine hydrochloride. In-vitro release profile.

作者: L. RAMIREZ

DOI: 10.1080/026520499289356

关键词: SolventPLGAMaterials scienceEmulsionPulmonary surfactantStereochemistryChromatographyGlycolic acidTetracaineDrug carrierDosage form

摘要: Tetracaine does not result in effective treatment of intractable pain caused by trigeminal neuralgiabecause its short duration effect. In asustained release system a controlled delivery the drug at site administration, would avoid successive administrations. hydrochloride (HCl) has been encapsulated using technique based on evaporation solvent from an O/O emulsion, poly(dl-lactic-co-glycolic acid) (PLGA) 50:50. Microspheres were separated into three fractions: 106-212, 212-300 and 300-425mum. The effects two variables manufacturing method (volume inner phase emulsion volume surfactant added to external phase) loading microspheres, dissolution profiles SEM characterization microspheres evaluated. containing tetracaine (up to94% referred tothe theoretical) released drug, in-vitro, over 35 days. HCl was delivered according zero order kinetics day 5 un...

参考文章(10)
Smadar Cohen, Toshio Yoshioka, Melissa Lucarelli, Lena H. Hwang, Robert Langer, Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres Pharmaceutical Research. ,vol. 8, pp. 713- 720 ,(1991) , 10.1023/A:1015841715384
R. Bodmeier, J.W. McGinity, Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method International Journal of Pharmaceutics. ,vol. 43, pp. 179- 186 ,(1988) , 10.1016/0378-5173(88)90073-7
Thomas R. Tice, Richard M. Gilley, Preparation of injectable controlled-release microcapsules by a solvent-evaporation process Journal of Controlled Release. ,vol. 2, pp. 343- 352 ,(1985) , 10.1016/0168-3659(85)90056-2
NAOKI WAKIYAMA, KAZUHIKO JUNI, MASAHIRO NAKANO, Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics. Chemical & Pharmaceutical Bulletin. ,vol. 29, pp. 3363- 3368 ,(1981) , 10.1248/CPB.29.3363